EU 2024/1860 IVDR Transition Timeline and ÜTS: Final Dates for Class A/B/C/D Devices
SUMMARY
Regulation (EU) 2024/1860 redefined the IVDR transition periods for in vitro diagnostic devices placed on the market under the IVDD according to class: 31.12.2027 for Class D, 31.12.2028 for Class C, and 31.12.2029 for Class B and sterile Class A. In Türkiye, the same dates have been incorporated into Article 1 of the Transitional Provisions of the In Vitro Diagnostic Medical Device Regulation.
This guide explains which device may be placed on the market until which date, the six conditions for benefiting from the transition period, the final dates for the application to and agreement with a notified body, and the relationship of these dates to the ÜTS registration, through the text of the regulation and Article 48 of the Guideline on Registration Processes of Medical Devices to the Product Tracking System (TCKKD-KLVZ-03) (unofficial translations). The steps of the EBS and ÜTS application are in a separate guide.
For the definition of the transition period of your IVD devices and the ÜTS document registration: Medical Device ÜTS Registration Consultancy
Contents
1. What Is (EU) 2024/1860?2. Certified Devices: 31.12.20273. Self-Declared Devices: 2027, 2028, 2029 by Class4. The Six Conditions for Benefiting from the Transition Period5. Application to and Agreement with a Notified Body: Dates6. The Situation According to the Document End Date7. Relationship of the Dates to the ÜTS Registration8. Checklist9. Frequently Asked Questions10. Related Guides
1. What Is (EU) 2024/1860?
According to the first paragraph of Article 48 of the Guideline, the Regulation was prepared to reduce the risk of high-risk IVD devices becoming unavailable on the market, to make the EUDAMED modules mandatory gradually, and to give advance notice of supply interruptions; it was published in the Official Journal of the EU on 09.07.2024 and entered into force. For its counterpart in Türkiye, the second paragraph of the same article:
“Within the scope of harmonization work with the current EU medical device legislation, in parallel with the Regulation mentioned in the first paragraph of this article, the Regulation titled "Regulation Amending the In Vitro Diagnostic Medical Device Regulation" was published in the Official Gazette dated 2/4/2023 and numbered 32151. The said amendments have been reflected in the IVDR.”
The current dates in Article 1 of the Transitional Provisions of the Regulation came with the amendment published in the Official Gazette dated 17/8/2024 and numbered 32635.
The transition period varies according to the class of the device and the type of the IVDD document.
2. Certified Devices: 31.12.2027
For devices with a notified body certificate under the IVDD, the third paragraph of Article 48 of the Guideline:
“Provided that the conditions specified in the Regulation mentioned in the first paragraph of this article are fulfilled, devices placed on the market under the IVDD as Annex-2 List-A, Annex-2 List-B and Self-Test Devices may be placed on the market or put into service until 31.12.2027.”
For the certificate itself, subparagraph (b) of the third paragraph of Article 1 of the Transitional Provisions of the In Vitro Diagnostic Medical Device Regulation:
“Certificates issued by notified bodies in accordance with the In Vitro Diagnostic Medical Devices Regulation repealed by Article 107 as of 25/5/2017, which are still valid on 26/5/2022 and are not subsequently withdrawn, continue to remain valid until 31/12/2027 after the end of the period specified in the certificate.”
According to the same subparagraph, certificates that were valid on 26/5/2022 and expire before 9/7/2024 are considered valid until 31/12/2027, provided that a written agreement was signed between the manufacturer and the notified body before the expiry date or that the Agency took action under Article 56 or 91.
3. Self-Declared Devices: 2027, 2028, 2029 by Class
For devices that did not require a notified body under the IVDD, for which a declaration of conformity was drawn up before 26 May 2022 and which require a notified body under the IVDR, the fourth paragraph of Article 48 of the Guideline:
“Devices to be classified as Class D, Self-Test Device (Class D), Near-Patient Test Device (Class D) and Companion Diagnostic Device (Class D) under the IVDR, until 31.12.2027,”
“Devices to be classified as Class C, Self-Test Device (Class C), Near-Patient Test Device (Class C) and Companion Diagnostic Device (Class C) under the IVDR, until 31.12.2028,”
“Devices to be classified as Class B, Near-Patient Test Device (Class B) and Class A Sterile under the IVDR, until 31.12.2029,”
may be placed on the market or put into service. Non-sterile Class A devices are not on this list: since they do not require a notified body under the IVDR either, they remain outside the transition provision. To determine your class, see our guide on the ÜTS product registration of IVD devices.
4. The Six Conditions for Benefiting from the Transition Period
The dates alone are not enough. According to subparagraph (ç) of the fourth paragraph of Article 1 of the Transitional Provisions of the In Vitro Diagnostic Medical Device Regulation, devices may be placed on the market until these dates only if the following conditions are met:
“These devices continue to comply with the In Vitro Diagnostic Medical Devices Regulation repealed by Article 107.”
“There is no significant change in the design and intended purpose.”
“The devices do not present an unacceptable risk to the health or safety of patients, users or other persons, or to other aspects of the protection of public health.”
“By 26/5/2025, the manufacturer puts in place a quality management system in accordance with the eighth paragraph of Article 11.”
The fifth and sixth conditions concern the notified body and have their own calendars; they are in the section below.
5. Application to and Agreement with a Notified Body: Dates
According to sub-subparagraph 5 of the same subparagraph, the manufacturer or the authorized representative must have formally applied to a notified body by the following dates at the latest:
26/5/2025: certified devices and self-declared devices that will be Class D.
26/5/2026: devices that will be Class C.
26/5/2027: devices that will be Class B and sterile Class A.
According to sub-subparagraph 6, the notified body and the manufacturer must sign the written agreement by the following date at the latest:
“26/9/2025 for the devices referred to in subparagraph (b) and in sub-subparagraph (1) of subparagraph (c).”
26/9/2026 for devices that will be Class C, and 26/9/2027 for devices that will be Class B and sterile Class A (sub-subparagraphs ii and iii of the same sub-subparagraph).
6. The Situation According to the Document End Date
In practice in Türkiye, the end date of the EC certificate is decisive. The second paragraph of Article 49 of the Guideline distinguishes four situations:
End date before 26.05.2022: according to subparagraph (a), no extension is applied.
Valid on 26.05.2022, ends before 09.07.2024, the IVDR notified body was applied to before the end date and the agreement was signed: subparagraph (b); EBS application with the manufacturer's declaration, the notified body document and the surveillance responsibility document.
The same certificate, agreement signed after the end date: subparagraph (c); in addition, the permission under Article 56 or the request under Article 91 obtained from the Agency.
End date 09.07.2024 or later: subparagraphs (ç) and (d); the document set varies according to whether an application was made to the notified body.
In all four situations, the application is made in EBS with the "Time Extension Application No. 2023/KK-1" document type, without physical documents. For the content of the statements and documents and the second step in ÜTS, see our guide on the IVDR transition period extension: EBS and ÜTS application.
7. Relationship of the Dates to the ÜTS Registration
The fifth paragraph of Article 48 of the Guideline sets the order:
“In order for companies to benefit from the IVDR transition provisions for their devices within the scope of the third and fourth paragraphs of this article, they must first make an application through EBS under Article 49 of this Guideline, and afterwards, if the Agency finds their application in EBS appropriate, they must make medical device (and/or document) registration/update applications in ÜTS for the relevant devices and their linked documents under Article 50 of this Guideline.”
A document update application made in ÜTS without EBS approval is rejected (Article 50, second paragraph, subparagraph (a) of the Guideline). For the general flow of document registration, see our guide on ÜTS document registration under the IVDR; for the whole registration, see our ÜTS consultancy page.
8. Checklist
Which path was the device on under the IVDD: a notified body certificate or self-declaration?
Which class will it fall into under the IVDR: D, C, B or sterile A? (There is no transition period for non-sterile A.)
Was the declaration of conformity drawn up before 26 May 2022?
Has there been a significant change in the design or intended purpose?
Was the quality management system put in place by 26/5/2025?
Was the notified body applied to before the final date for the class; was the written agreement signed?
Which subparagraph does the end date of the EC certificate fall under; was the EBS application made?
9. Frequently Asked Questions
What is the final date for Class D IVD devices?
31.12.2027. Both IVDD-certified devices and self-declared devices that will be Class D under the IVDR may be placed on the market until this date (TCKKD-KLVZ-03 Article 48, third and fourth paragraphs).
What are the final dates for Class C and Class B devices?
31.12.2028 for Class C; 31.12.2029 for Class B and sterile Class A.
Is there a transition period for non-sterile Class A devices?
No. The transition period provision is for devices that require a notified body under the IVDR; non-sterile Class A is not within this scope.
When should the notified body be applied to in order to benefit from the transition period?
The final application date is 26/5/2025 for certified and Class D devices, 26/5/2026 for Class C, and 26/5/2027 for Class B and sterile A (In Vitro Diagnostic Medical Device Regulation, Transitional Provisions Article 1, fourth paragraph, subparagraph (ç)).
Is an IVDD certificate whose end date is before 26.05.2022 extended?
No. According to Article 49 of the Guideline, no extension is applied to these certificates.
What is done first in Türkiye for the extension?
First, "Time Extension Application No. 2023/KK-1" is made in EBS; if the Agency finds it appropriate, a document and device update application is made in ÜTS. A ÜTS application without EBS approval is rejected.
10. Related Guides
IVDR transition period extension: EBS and ÜTS application step by step
ÜTS document registration under the IVDR
ÜTS product registration of IVD devices
IVDR declaration of conformity
EU 2023/607 MDR transition timeline
IVDR transition period and IVD registration consultancy
For the definition of the transition period of your IVD devices and the ÜTS document registration: Medical Device ÜTS Registration Consultancy
Sources
TİTCK: Guideline on Registration Processes of Medical Devices to the Product Tracking System (TCKKD-KLVZ-03), Articles 48, 49 and 50
In Vitro Diagnostic Medical Device Regulation, Transitional Provisions Article 1



